Clinical Trial Update: The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

View source ↗

Summary

Completed clinical trial evaluating the relationship between fever resolution (defervescence) and itraconazole plasma levels in immunocompromised participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Neutropenia

Drugs mentioned

• SPORANOX (Itraconazole)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Hematologic Neoplasms, Neutropenia | Status: COMPLETED | Results posted: 2013-07-03